Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2007 Oct 5.

Published in final edited form as: Biol Blood Marrow Transplant. 2007 Apr 6;13(6):691–700. doi: 10.1016/j.bbmt.2007.02.002

Table 3.

Leave one out validation (LOOV) of the predictive power of CD3⁺CD4⁺CD8β⁺ and other populations with the development acute GvHD.

	All patients w/GvHD	Grade II-IV GvHD	Grade III/IV GvHD

Cell population	Sensitivity/Specificity (%)
CD3⁺CD4⁺CD8β⁺	86/100	92/100	83/100
CD3⁺CD8β ⁺CD4⁺CD8⁺	71/100	83/100	76/100
CD3⁺CD8β ^dimCD8⁻	90/0	82/67	83/67
CD3⁺CD8β ⁺CD4⁻	81/33	76/33	75/33
CD3⁺CD8⁺CD8β⁻	81/33	76/33	75/33
CD3⁺CD4⁺CD8β⁻	90/33	100/33	100/0
CD3⁺	90/33	94/33	92/33